Abstract��OBJECTIVE To investigate the curative effect of Shugan granule in the treatment of post-stroke depression (PSD) and effect on brain devived neurotrophic factor(BDNF) and inflammatory factors.METHODS Eighty Patients with PSD were randomly divided into control group and study group, 80 cases in each group. Besides routine treatment, control group received citalopram hydrobromide 20 mg��d-1. Study group received Shugan granule 1 bags��time-1, twice a day based on control group.8 weeks for a course of treatment. HAMD scores, BI index, BDNF and inflammatory factors levels were compared.RESULTS The total effective rate in study group was significantly higher than that in control group[71 cases,88.75% vs 61 cases, 76.25%, ��2=4.329, P<0.05]. Repeated measurement data analysis of variance showed, the overall scores of HAMD in study group were significantly lower than those in control group [Fgroup=36.541, P<0.05]. The HAMD scores of the two groups decreased with the extension of treatment time [Ftime=668.574, P<0.05].The reduction extent of HAMD score in study group was significantly higher than that in control group[Fgroup��time=18.495, P<0.05]. BI indexes and BDNF levels in study group were significantly higher than those in control group [Fgroup=48.147, 41.561, P<0.05]. BI indexes and BDNF levels of two groups increased with the extension of treatment time [Ftime=316.586, 595.864, P<0.05]. The increasing extent of BI indexes and BDNF levels in study group was significantly higher than that in control group [Fgroup��time=22.849, 10.515, P<0.05]. The overall levels of TNF-��, IL-6 and hs-CRP in study group were significantly lower than those in control group [Fgroup=117.849, 85.168, 66.763, P<0.05]. TNF-��, IL-6 and hs-CRP levels of two groups decreased with the extension of treatment time [Ftime=864.584, 697.717, 1 037.167, P<0.05]. The reduction extent of TNF-��, IL-6 and hs-CRP levels in study group was significantly higher than that in control group[Fgroup��time=31.271, 26.174, 17.585, P<0.05]. There was no significant difference in adverse reactions between the two groups [9 cases, 11.25% vs 15 cases, 18.75%, ��2=1.765, P>0.05].CONCLUSION On the basis of conventional western medicine treatment, Shugan granules can improve the degree of depression and reduce the level of inflammatory factors in patients with PSD.
����Ϫ,�ﺣ��,������,�����,ʷ��ƽ,���Ӻ�,����ƽ. ��ο��������Թ���������֢����Ч����BDNF����֢����ˮƽ��Ӱ��[J]. �й�ҩѧ��־, 2018, 53(13): 1140-1144.
LIU Xiao-xi, SUN Hai-min, SHANG Meng-meng, LI Hui-min, SHI Fu-ping, ZHANG Xing-hong, SONG Yue-ping. The Curative Effect of Shugan Granule in the Treatment of Post-stroke Depression and Effect on BDNF and Inflammatory Factors. Chinese Pharmaceutical Journal, 2018, 53(13): 1140-1144.
WAN Q R,HU Y R, LIU H, et al. Effects of sertraline in early prophylactic treatment on neurological rehabilitation in patients with acute cerebral infarction[J]. Chin Hosp Pharm J (�й�ҽԺҩѧ��־),2015,35(19):1768-1771.
[2]
HU D,SHENG L. Clinical observation on efficacy of modified Chaihu Shugan Granule for treating post ischemic stroke depression[J]. Chin Tradit Herb Drugs(�в�ҩ), 2016, 47(21):3866-3870.
[3]
MACINTOSH B J, EDWARDS J D, KANG M, et al. Post-stroke fatigue and depressive symptoms are differentially related to mobility and cognitive performance[J]. Front Aging Neurosci, 2017, 31;9:343. doi: 10.3389/fnagi.2017.00343.
[4]
Psychiatric Association of Chinese Medical Association. Classification and diagnosis standard of mental disorders in China[S]. 3rd ed,2000.
[5]
Neurological branch of Chinese Medical Association. Key points of diagnosis for various cerebrovascular diseases[J]. Chin J Neurol (�л�����־), 1996, 29(6):371-379.
[6]
The State Administration of traditional Chinese medicine. Diagnostic criteria for TCM syndromes[S]. 1994.
[7]
Guidelines for clinical research of new Chinese medicine (Trial Implementation)[S]. 2002.
[8]
Chinese Society of Traditional Chinese Medicine. Guidelines for Diagnosis and Treatment of Common Diseases in Internal Medicine of Traditional Chinese Medicine(��ҽ�ڿƳ���������ָ��)[M]. Beijing: China Traditional Chinese Medicine Press, 2008:231-250.
[9]
HUANG Y, XU W P, ZHANG Y L, et al. A clinical observation of Rhizoma Polygonati Combined with mirtazapine in treatment of elderly post-cerebral infarction depression[J]. Anhui Med Pharm J(����ҽҩ),2017,21(9):1702-1705.
[10]
SUN N, LI Q J, LV D M, et al. A survey on 465 patients with post-stroke depression in China[J]. Arch Psychiatr Nurs, 2014,28(6):368-371.doi: 10.1016/j.apnu.2014.08.007.
[11]
PANG J Y, GUO H R, SHI Y X, et al. Effects of Shugan Granule in treatment of anxiety disorders[J]. Neur Dis Ment Hyg(�����뾫������),2013, 13(1):33-36.
[12]
CHENG F, SHAO G F, BAO S Y, et al. Study of effect on neurologic function rehabilitation in patient with post-strok depression[J]. Chin J Clin Rehabil(�й��ٴ�����), 2003, 7(1):108-109.
[13]
GUO M,LI H L, HUANG Y L, et al. Relationship between post-stroke depression and serum cytokines[J]. Chin Ment Health J (�й�����������־), 2008, 22(2):101-104.
[14]
MIAO X Q, GUO J J, WU X Y, et al. Investigation and analysis of the correlation between IL-1, IL-18, hs-CRP and post-stroke depression[J]. Shenzhen J Integr Tradit Chin West Med (��������ҽ�����־), 2017,27(5):3-5.
[15]
NIU H L, MA L, WANG L C, et al. Expression of IL-1, IL-2, IL-6 and TNF- alpha in serum of patients with post-stroke depression and its clinical significance[J]. Mod Med J(�ִ�ҽѧ), 2016,44(1):89-91.
2018, Vol. 53 
